Good evening :)
Jeena Sikho Lifecare Ltd

Jeena Sikho Lifecare Ltd

JSLL Share Price

NSE
510.403.95% (+19.40)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹6,344 cr, stock is ranked 776

Stock is 4.10x as volatile as Nifty

JSLL Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹6,344 cr, stock is ranked 776

Stock is 4.10x as volatile as Nifty

JSLL Performance & Key Metrics

JSLL Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
26.8313.590.88%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
47.205.920.48%

JSLL Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

JSLL Company Profile

Jeena Sikho Lifecare is engaged in developing health care products and providing ayurvedic healthcare services in India.

Investor Presentation

View older View older 

Aug 9, 2026

PDF
View Older Presentations

JSLL Similar Stocks (Peers)

Compare with peers Compare with peers 

JSLL Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
38.40
38.40
1Y Return
11.45%
11.45%
Buy Reco %
93.33
93.33
PE Ratio
85.10
85.10
1Y Return
35.67%
35.67%
Buy Reco %
81.48
81.48
PE Ratio
22.96
22.96
1Y Return
10.70%
10.70%
Buy Reco %
55.56
55.56
PE Ratio
29.04
29.04
1Y Return
11.64%
11.64%
Buy Reco %
62.86
62.86
LAURUSLABS
PE Ratio
118.79
118.79
1Y Return
111.64%
111.64%
Buy Reco %
58.33
58.33
Compare with Peers

JSLL Sentiment Analysis

JSLL Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

JSLL Stock Summary · August 2026

Management described a quarter of strong profitability alongside continued investment in a long-term preventive healthcare buildout. Revenue from operations was INR 224 crore in Q1 FY27, while EBITDA reached INR 92 crore and PAT was INR 65 crore, with a 41% EBITDA margin and 28% PAT margin underscoring the scalability it sees in the model. At the same time, management said the business should be judged on its multi-year trajectory rather than any single quarter, as patient count and volume rose 10% sequentially, day-care volume increased from 16,000 to 19,000, and consultation growth signaled a larger funnel that should convert over time. It framed the strategy around keeping patients engaged across awareness, consultation, lifestyle support, services and products, with a 50-50 balance between services and products and a deliberate shift toward a more cash-rich mix after reducing government business. Management also pointed to 47% growth in Ayurveda products and 13% growth in Panchakarma, while noting about INR 6.5 crore of incremental spending on marketing, software and governance. Near term, it expects more beds, rising day-care activity, and continued growth in private business and OTC distribution.

JSLL Stock Growth Drivers
JSLL Stock Growth Drivers
10
  • Strong Profitability and Scalable FY27 Growth

    The company delivered a strong start to FY27, with Q1 revenue from operations of INR

  • Preventive Healthcare Ecosystem With Recurring Engagement

    The company is building a prevention-led healthcare platform that connects awareness, health camps, consultations, OPD,

JSLL Stock Challenges
JSLL Stock Challenges
6
  • Elevated operating costs from governance, technology, marketing, and wage-law changes

    The quarter reflected a clear step-up in operating expenses driven by multiple one-time or above-normal

  • Weak economics of offline OTC expansion

    The company’s OTC strategy faces unfavorable channel economics in physical retail. Management acknowledged that medical

JSLL Forecast

JSLL Forecasts

Price

Revenue

Earnings

JSLL

JSLL

Income

Balance Sheet

Cash Flow

JSLL Income Statement

JSLL Income Statement

Loading...

Quarterjun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026jun 2026
Total Revenue102.67117.54116.08139.52175.35191.29224.25218.97238.73
Operating & Other expensessubtract75.0973.8286.0893.4895.5397.82120.96137.63132.34
Depreciation/Amortizationsubtract5.366.258.479.039.6510.4011.2616.3815.39
Interest & Other Itemssubtract1.702.073.793.101.664.353.103.733.47
Taxes & Other Itemssubtract4.798.814.538.5817.2219.9722.2716.0921.58
EPS0.250.430.210.414.124.735.363.635.30

JSLL Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2027FY 2027

Annual Report Pending

Investor Presentation

Aug 9PDF
FY 2026FY 2026

Annual report

PDF

Investor Presentation

Jun 1PDF
May 31PDF
Feb 8PDF
+3 more
FY 2025FY 2025

Annual report

PDF
 

JSLL Stock Peers

JSLL Past Performance & Peer Comparison

JSLL Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Jeena Sikho Lifecare Ltd28.6213.590.88%
Sun Pharmaceutical Industries Ltd38.405.260.87%
Torrent Pharmaceuticals Ltd85.1010.470.70%
Zydus Lifesciences Ltd22.963.910.09%

JSLL Stock Price Comparison

Compare JSLL with any stock or ETF
Compare JSLL with any stock or ETF
JSLL
Loading...

JSLL Holdings

JSLL Shareholdings

JSLL Promoter Holdings Trend

JSLL Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

JSLL Institutional Holdings Trend

JSLL Institutional Holdings Trend

Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 2.76%

Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has decreased by 1.38%

Tickertape Separator

JSLL Shareholding Pattern

JSLL Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding63.62%0.10%0.26%4.78%31.23%

Sep 2025

Dec 2025

Mar 2026

Jun 2026

JSLL Shareholding History

JSLL Shareholding History

JunAugSepDec '25MarJun5.91%5.99%6.59%6.31%6.17%4.78%

Mutual Funds Invested in JSLL

Mutual Funds Invested in JSLL

No mutual funds holding trends are available

Top 5 Mutual Funds holding Jeena Sikho Lifecare Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
0.0905%0.24%-0.06%116/256 (-6)
0.0007%0.01%-0.00%684/755 (-24)
0.0001%0.01%-0.00%667/756 (-33)

Compare 3-month MF holding change on Screener

JSLL Insider Trades & Bulk Stock Deals

JSLL Insider Trades & Bulk Stock Deals

Loading...

smallcases containing JSLL stock

smallcases containing JSLL stock

Looks like this stock is not in any smallcase yet.

JSLL Events

JSLL Events

JSLL Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

JSLL Dividend Trend

No dividend trend available

JSLL Upcoming Dividends

JSLL Upcoming Dividends

Cash Dividend

Ex DateEx DateSep 21, 2026

Final
Final | Div/Share: ₹4.50

Dividend/Share

4.50

Ex DateEx Date

Sep 21, 2026

JSLL Past Dividends

JSLL Past Dividends

Cash Dividend

Ex DateEx DateSep 22, 2025

Final
Final | Div/Share: ₹1.10

Dividend/Share

1.10

Ex DateEx Date

Sep 22, 2025

Cash Dividend

Ex DateEx DateAug 20, 2024

Final
Final | Div/Share: ₹4.18

Dividend/Share

4.18

Ex DateEx Date

Aug 20, 2024

Cash Dividend

Ex DateEx DateAug 25, 2023

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Aug 25, 2023

JSLL Stock News & Opinions

JSLL Stock News & Opinions

Earnings
Earnings
Jeena Sikho Lifecare Ltd consolidated sales up 4.11% on year in Q2FY2026, net profit jumped 46.16%

Jeena Sikho Lifecare Ltd share price slipped 1.20% to Rs 597.05. The Company's net profit soared by 46.16% to Rs 65.89 crore, while revenue from operations slightly gained 4.11% to Rs 224.4 crore in Q2FY26 over Q1FY26. The market capitalization of Wellness industry group stocks on BSE stood at Rs 9551.42 crore, tanking 25.17%. It has improved by 2.82% over last one week and collapsed sharply by 17.88% in last one month while the market capitalization of Jeena Sikho Lifecare Ltd has marginally improved by 3.06% and 19.10% in the same period respectively. Profit before tax (PBT) of Jeena Sikho Lifecare Ltd stood at Rs 87.53 crore in Q2 FY26, rallying 27.76% year-on-year, and jumping 42.95% quarter-on-quarter. EBITDA came in at Rs 78 crore, easing 0.08% YoY and gaining 4.35% sequentially. Total expenses softened by 4.08% to Rs 147.73 crore in Q2FY26 over Q2FY25. During the quarter, employee benefits expense was at Rs 44.18 crore, seeing a marginal contraction of 3.94% YoY. For the TTM ended FY26, revenue from operations jumped by 39.71% to Rs 204.75 crore, while net profit surged by 199.55% to Rs 33.52 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 1545% to Rs 43.0 crore, and PBT surged 193.51% to Rs 44.29 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 14.52 crore in FY26, as against Rs 16.35 crore in FY25. Jeena Sikho Lifecare Ltd rallied 11.24% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 2.63% during the same period.

1 month agoCapital Market - Live
Earnings
Earnings
Jeena Sikho Lifecare Ltd consolidated sales up 4.11% on year in Q2FY2026, net profit soared by 46.16%

Jeena Sikho Lifecare Ltd share price declined by 1.20% to Rs 597.05. The Company's net profit surged by 46.16% to Rs 65.89 crore, while revenue from operations improved marginally 4.11% to Rs 224.4 crore in Q2FY26 over Q1FY26. The market capitalization of Wellness industry group stocks on BSE stood at Rs 9699.43 crore, tumbling by 25.17%. It has marginally improved by 1.60% over last one week and crashed 19.14% in last one month while the market capitalization of Jeena Sikho Lifecare Ltd has inched up 1.77% and 20.13% in the same period respectively. Profit before tax (PBT) of Jeena Sikho Lifecare Ltd stood at Rs 87.53 crore in Q2 FY26, rallying 27.76% year-on-year, and jumping 42.95% quarter-on-quarter. EBITDA came in at Rs 78 crore, rising 0.08% YoY and gaining 4.35% sequentially. Total expenses slightly declined by 4.08% to Rs 147.73 crore in Q2FY26 over Q2FY25. During the quarter, employee benefits expense was at Rs 44.18 crore, seeing a marginal contraction of 3.94% YoY. For the TTM ended FY26, revenue from operations witnessed a strong growth of 39.71% to Rs 204.75 crore, while net profit saw a strong growth of 199.55% to Rs 33.52 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 1545% to Rs 43.0 crore, and PBT witnessed a strong rise of 193.51% to Rs 44.29 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 14.52 crore in FY26, as against Rs 16.35 crore in FY25. Jeena Sikho Lifecare Ltd jumped 11.24% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 2.63% during the same period.

1 month agoCapital Market - Live
Spotlight
Spotlight
Jeena Sikho Lifecare Ltd leads gainers in 'B' group

Thacker & Company Ltd, HLE Glascoat Ltd, SKM Egg Products Export (India) Ltd and HCL Infosystems Ltd are among the other gainers in the BSE's 'B' group today, 02 June 2026.Jeena Sikho Lifecare Ltd surged 16.35% to Rs 573.1 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 11.14 lakh shares were traded on the counter so far as against the average daily volumes of 46082 shares in the past one month. Thacker & Company Ltd soared 15.21% to Rs 1440.1. The stock was the second biggest gainer in 'B' group. On the BSE, 347 shares were traded on the counter so far as against the average daily volumes of 23 shares in the past one month. HLE Glascoat Ltd spiked 13.27% to Rs 362. The stock was the third biggest gainer in 'B' group. On the BSE, 51173 shares were traded on the counter so far as against the average daily volumes of 8835 shares in the past one month. SKM Egg Products Export (India) Ltd jumped 13.04% to Rs 233.15. The stock was the fourth biggest gainer in 'B' group. On the BSE, 3.72 lakh shares were traded on the counter so far as against the average daily volumes of 74654 shares in the past one month. HCL Infosystems Ltd advanced 12.45% to Rs 13.64. The stock was the fifth biggest gainer in 'B' group. On the BSE, 2.58 lakh shares were traded on the counter so far as against the average daily volumes of 58502 shares in the past one month. Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
Spotlight
Jeena Sikho Lifecare Ltd leads losers in 'B' group

Arihant Foundations & Housing Ltd, Coastal Corporation Ltd, Birla Precision Technologies Ltd and RPP Infra Projects Ltd are among the other losers in the BSE's 'B' group today, 01 June 2026.Jeena Sikho Lifecare Ltd crashed 20.00% to Rs 491.95 at 14:31 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 2.95 lakh shares were traded on the counter so far as against the average daily volumes of 31843 shares in the past one month.Arihant Foundations & Housing Ltd lost 19.45% to Rs 735.55. The stock was the second biggest loser in 'B' group.On the BSE, 8628 shares were traded on the counter so far as against the average daily volumes of 4419 shares in the past one month.Coastal Corporation Ltd tumbled 17.77% to Rs 49.78. The stock was the third biggest loser in 'B' group.On the BSE, 31753 shares were traded on the counter so far as against the average daily volumes of 12772 shares in the past one month.Birla Precision Technologies Ltd shed 16.05% to Rs 38.91. The stock was the fourth biggest loser in 'B' group.On the BSE, 1.18 lakh shares were traded on the counter so far as against the average daily volumes of 68697 shares in the past one month.RPP Infra Projects Ltd dropped 14.21% to Rs 64.66. The stock was the fifth biggest loser in 'B' group.On the BSE, 17874 shares were traded on the counter so far as against the average daily volumes of 5902 shares in the past one month.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Corporate
Board of Jeena Sikho Lifecare recommends final dividend

Jeena Sikho Lifecare announced that the Board of Directors of the Company at its meeting held on 30 May 2026, inter alia, have recommended the final dividend of Rs 4.5 per equity Share (i.e. 225%) , subject to the approval of the shareholders.

3 months agoCapital Market - Live
Earnings
Earnings
Jeena Sikho Lifecare consolidated net profit rises 78.10% in the March 2026 quarter

Net profit of Jeena Sikho Lifecare rose 78.10% to Rs 45.13 crore in the quarter ended March 2026 as against Rs 25.34 crore during the previous quarter ended March 2025. Sales rose 54.79% to Rs 215.55 crore in the quarter ended March 2026 as against Rs 139.25 crore during the previous quarter ended March 2025. For the full year,net profit rose 177.52% to Rs 221.85 crore in the year ended March 2026 as against Rs 79.94 crore during the previous year ended March 2025. Sales rose 70.84% to Rs 801.36 crore in the year ended March 2026 as against Rs 469.07 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales215.55139.25 55 801.36469.07 71 OPM %36.1532.87 -43.6029.97 - PBDT77.6142.94 81 345.09136.68 152 PBT61.2333.92 81 297.39107.58 176 NP45.1325.34 78 221.8579.94 178 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Corporate
Jeena Sikho Lifecare announces board meeting date

Jeena Sikho Lifecare will hold a meeting of the Board of Directors of the Company on 30 May 2026.

3 months agoCapital Market - Live
Corporate
Corporate
Jeena Sikho Lifecare receives NABH accreditation for its Noida Hospital

Jeena Sikho Lifecare has been awarded the National Accreditation Board for Hospitals & Healthcare Providers (NABH) Certificate of Accreditation for its Noida Hospital.

5 months agoCapital Market - Live
Corporate
Corporate
Jeena Sikho Lifecare receives NABH accreditation for Dehradun Hospital

Jeena Sikho Lifecare has been awarded the National Accreditation Board for Hospitals & Healthcare Providers (NABH) Certificate of Accreditation for its Dehradun Hospital. The receipt of this NABH accreditation signifies adherence to nationally recognized standards for quality healthcare delivery, patient safety, and operational excellence. This development has occurred in the ordinary course of business and does not constitute business expansion, capacity enhancement, or acquisition.Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
Earnings
Jeena Sikho Lifecare standalone net profit rises 405.15% in the December 2025 quarter

Net profit of Jeena Sikho Lifecare rose 405.15% to Rs 66.73 crore in the quarter ended December 2025 as against Rs 13.21 crore during the previous quarter ended December 2024. Sales rose 91.60% to Rs 221.66 crore in the quarter ended December 2025 as against Rs 115.69 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales221.66115.69 92 OPM %45.4825.59 - PBDT100.2726.21 283 PBT89.0617.74 402 NP66.7313.21 405 Powered by Capital Market - Live

7 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. The share price of JSLL as on 18th September 2026 is ₹510.40. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. The past returns of Jeena Sikho Lifecare Ltd (JSLL) share are
    • Past 1 week: -0.75%
    • Past 1 month: -0.33%
    • Past 3 months: -7.11%
    • Past 6 months: -18.71%
    • Past 1 year: -37.84%
    • Past 3 years: 343.44%
    • Past 5 years: 2550.05%

  3. The current dividend yield of Jeena Sikho Lifecare Ltd (JSLL) is 0.88.

  4. Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Jeena Sikho Lifecare Ltd (JSLL) is ₹6344.31 Cr as of 18th September 2026.

  5. The 52-week high of Jeena Sikho Lifecare Ltd (JSLL) is ₹849.50 and the 52-week low is ₹485.10.

  6. The P/E (price-to-earnings) ratio of Jeena Sikho Lifecare Ltd (JSLL) is 28.62. The P/B (price-to-book) ratio is 13.59.

  7. Jeena Sikho Lifecare Ltd (JSLL) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. You can directly buy Jeena Sikho Lifecare Ltd (JSLL) shares on Tickertape. Simply sign up, connect your demat account and place your order.